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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Dysfunctional voiding (DV) is anabnormality of bladderemptying inneurolog-
ically normal individuals where the external sphincter activity increases during voiding. This study
investigated the clinical presentations and videourodynamic characteristics of adultwomenwithDV.
Methods: A total of 1605 women with lower urinary tract symptoms (LUTS) were investigated with
videourodynamic (VUD) studies from1997 to 2010. The clinical urinary symptoms andVUD character-
istics of DVwere comparedwith a group of urodynamically normal controls. Antimuscarinic or alpha-
blocker treatmentaccording to thechief complaint of storageor voidingLUTSwas respectively given.
Results: There were 168 women diagnosed with DV. Detrusor overactivity (DO) occurred in 69% of
womenwith DV. Patientswith DV had significantly lower cystometric bladder capacity, higher detru-
sor pressure, lower maximum flow rate, and larger post-void residual volume than the controls. A
totalof114 (67.9%)patientshadstoragesymptomsand54 (32.1%)hadvoiding symptomsas their chief
complaints among those with DV. Among them, urinary frequency (nZ 69, 41.1%) was the most
common chief complaint, followed by dysuria (nZ 53, 32.1%), and urgency incontinence (nZ 26,
15.5%). The incidence of urgency incontinence and dysuria were significantly greater than that in
the control group, however, the incidence of frequency, urgency, or nocturia showed no significant
difference between DVand control groups. The success rateswere 41.2% (nZ 47) for antimuscarinic
therapy and 51.9% (nZ 28) for alpha-blocker therapy in patients with storage and voiding LUTS,
respectively (pZ 0.366).
Conclusion: DO and storage LUTS commonly occurred inwomenwith DV, suggesting DO could be one
of the etiology in the pathophysiology of DV. VUD studies yielded a high diagnostic rate for DV in
women with LUTS.
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the condition that patients could not urinate spontaneouslyDysfunctional voiding (DV) is an abnormality of bladder
emptying in neurologically normal individuals where the
external sphincter activity increases during voiding. In
1973, Hinman and Bauman1 popularized the concept of
incoordination between the detrusor and activity of the
pelvic floor-external sphincter complex. DV was first
described as the failure to coordinate the detrusor and
external sphincter in children in 1978.2 Since then, most DV
studies focused on the elimination syndrome and urinary
tract infection (UTI) in children. Nonetheless, this
phenomenon was also noted in women presenting with
lower urinary tract symptoms (LUTS)3 and is postulated to
be a learned voiding dysfunction in adults.4 Statistically
significantly more mothers of children with overactive
bladder (OAB) or DV reported having had similar symptoms
in their childhood. When OAB of childhood persists into
adulthood, it is likely to cause DV in the adult.5
Although DV is common in children and can be detected
early in those with characteristic clinical presentations or
recurrent UTIs, the differential diagnosis between DV and
detrusor overactivity (DO) in adult women is difficult and
can be inaccurate when based on LUTS alone. A video-
urodynamic study (VUDS) is an examination combining
voiding pressure, urine flow, and imaging studies during the
voiding phase and can provide great help in differentiating
DV from LUTS in women.6 An accurate diagnosis of DV is
essential in order to select correct treatment. Therefore,
we analyzed the clinical presentations and VUD charac-
teristics of women diagnosed with DV.
Patients and methods
This study was a retrospective analysis among a total of
1605 consecutive women with LUTS were analyzed from
1997 to 2010. All women who received VUD study had LUTS
that could not be eradicated after medical treatment or
physiotherapy for more than 3 months. The medical record
charts were reviewed, and the clinical LUTS, comorbidities,
VUD characteristics, urodynamic parameters, and result of
treatment were recorded in detail. Patients with pelvic
organ prolapse, genuine stress urinary incontinence,
previous genitourinary surgery, history of genitourinary
tract cancer, neurogenic voiding dysfunction, established
diagnosis of interstitial cystitis/painful bladder syndrome,
or active UTI were excluded. These female patients with
LUTS received VUD study for diagnosis. The diagnosis was
made according to International Continence Society (ICS)
terminology.7 If patients suffered from LUTS but normal in
VUD study, they were considered as urodynamically normal
and enrolled as control group.
The clinical symptoms of LUTS were recorded in detail.
The main symptom was defined as the most bothersome
symptom that drove patients to seek help. The LUTS
recorded were also clustered into storage symptoms
(including frequency, urgency, urgency incontinence, and
nocturia), voiding symptoms (including hesitancy, difficult
urination, slow stream, intermittency, terminal dribbling,
and urine retention), pain symptoms (including painful
sensation over bladder, urethra, or perineum), and post-micturition symptoms. Urinary retention was referred to
and catheterization was necessary to evacuate the bladder.
VUD studies were performed using multichannel urody-
namic equipment (Life-Tech, Houston, TX, USA) and a C-
arm fluoroscope (Toshiba, Tokyo, Japan) prior to any
treatment. The procedure was performed in the sitting
position with a 6 Fr dual-channel urethral catheter for
recording intravesical pressure and infusing warm normal
saline containing 20% urograffin and an 8 Fr rectal balloon
catheter to record the intra-abdominal pressure. The VUD
study was performed at a filling rate of 20e30 ml/minute.
The C-arm fluoroscope was positioned 45 degrees from the
buttock so that the urethra could be lengthened and the
bladder neck, urethral sphincter, and pelvic floor (distal)
urethra could be clearly identified. Urethral sphincter
electromyography (EMG) was recorded using surface patch
EMG electrodes placed at the perianal area. The VUD study
was repeated at least once to demonstrate reproducibility
of the findings during the first examination. All descriptions
and terminology of urodynamic parameters were in accor-
dance with the recommendations of the International
Continence Society.7
A voiding detrusor pressure (Pdet) at maximum flow rate
(Qmax) of more than 35 cm H2O was considered high Pdet,
8
10e35 cm H2O was considered normal Pdet, and 10 cm H2O
or less was considered low Pdet. DO was defined as
evidence of spontaneous detrusor contractions occurring
during bladder filling (phasic DO) or before uninhibited
detrusor contraction, voiding at bladder capacity (terminal
DO) during the urodynamic study. If patients had a strong
desire to void at a cystometric bladder capacity (CBC) of
less than 350 ml and without the occurrence of DO, they
were considered to have increased bladder sensation.
Bladder compliance was measured as the incrementally
increased cystometric volume at full bladder sensation
divided by the increased detrusor pressure.
The final diagnosis of DV was made based on the clinical
symptoms and the main VUD findings. Patients with a stable
bladder, normal bladder sensation, CBC > 350 ml, normal
detrusor Pdet, or low Pdet but a Qmax > 15 ml/second, and
PVR less than 10% of CBC were considered as urodynami-
cally normal. The Qmax during VUDS was also compared to
that in free uroflowmetry, the higher Qmax was adapted for
final analysis. DV was diagnosed when high Pdet, intermit-
tent or increased external sphincter EMG activity, and
a “spinning top” urethral appearance on cinefluoroscopy
during voiding occurred together. If patients were found to
have a neurologic disease, they were classified as having
external-detrusor sphincter dyssynergia but not DV.9,10 The
urodynamic parameters and clinical symptoms were
compared between patients with DV and controls.
Comorbidities were recorded from the medical records,
including gastrointestinal, skeletal muscular, autoimmu-
nity, and other systemic disorders. The VUD characteristics
were also compared between those with and without
comorbidities.
Antimuscarinic or alpha-blocker treatment, with or
without a skeletal muscle relaxant according to the chief
complaint of storage or voiding symptoms, respectively,
was given to patients with DV. Patients were treated for
1e3 months and the treatment results were recorded using






Frequency 69 (41.1%) 100 (36.8%) 0.42
Nocturia 3 (1.8%) 5 (1.8%) 0.16
Urgency 16 (9.5%) 15 (5.5%) 0.13
Urgency incontinence 26 (15.5%) 13 (4.8%) <0.001
Difficult urination 53 (32.1%) 54 (19.9%) 0.004
Urine retention 1 (0.6%) 3 (1.1%) 1.00
Residual sensation 0 3 (1.1%) 0.29
Dysfunctional voiding in adult women 163the validated 6-scale Patients Perception of Bladder
Condition questionnaire.11 An improvement in more than
two scales on the questionnaire was considered a treat-
ment success. The result of treatment in chart was
reviewed and recorded for analysis.
The statistical analysis was performed using SPSS for
Windows (Version 10.0, SPSS, Chicago, IL, USA). Student’s t-
test and chi-squared test were used to compare differences
between the DV and control groups for continuous and
categorical variables, respectively. A p value of less than
0.05 was considered statistically significant.Terminal dribbling 0 1 (0.4%) <0.001
Bladder pain 0 49 (18.0%) <0.001
Micturition pain 0 4 (1.5%) 0.30
DV Z dysfunctional voiding.
Table 3 Types of LUTS in DV and control patients.
DV Control p valueResults
Among the 1605 women with LUTS, 168 were diagnosed to
have DV (10.5%) and 272 were classified as urodynamically
normal and served as controls (16.9%). The mean age was
67.8  18.1 years in the DV group and 58.9  18.4 years in
the control group (p > 0.05). Table 1 lists the urodynamic
parameters of the DV and control groups. A significantly
smaller CBC, higher Pdet, lower Qmax, larger postvoid
residual volume, and lower bladder compliance occurred in
the DV group compared to the control group (pZ 0.000). Of
the 168 patients with DV, 116 (69%) had DO and 22 (13.1%)
had increased bladder sensation. All control patients had
stable bladders.
Among patients with DV, urinary frequency (n Z 69,
41.1%) was the most common chief complaint, followed by
difficult urination (n Z 53, 32.1%), and urgency inconti-
nence (n Z 26, 15.5%). A total of 114 (67.9%) patients had
storage symptoms and 54 (32.1%) had voiding symptoms as
their chief complaints among those with DV. The incidence
of urgency incontinence and difficult urination were
significantly greater than that in the control group,
however, the incidence of frequency, urgency, or nocturia
showed no significant difference between DV and control
groups (Table 2).
When we compared the different types of LUTS between
the DV and control groups, storage LUTS was present in 167
(99.4%) patients with DV and in the 270 (99.3%) control
group. Voiding LUTS was present in 88 (52.4%) of patients in







CBC (ml) 286  160 482  100 <0.001
Pdet (cm H2O) 49.1  17.4 18.8  8.98 <0.001
Qmax (ml/s) 11.3  7.56 20.5  7.95 <0.001
PVR (ml) 77.4  113 25.7  44.0 <0.001
Compliance
(ml/cm H2O)
63.0  82.1 120  121 <0.001
DO 116 (69%) 0 <0.001
IBS 22 (13.1%) 0 <0.001
CBC Z cystometric bladder capacity; DO Z detrusor over-
activity; DV Z dysfunctional voiding; IBS Z increased bladder
sensation; Pdet Z detrusor pressure; Qmax Z maximum flow
rate; PVR Z postvoid residual.LUTS was present in 27 (16.1%) of DV patients and 72
(26.5%) of controls while postmicturition LUTS occurred in
two (0.74%) of the control patients, but in no patient with
DV. A significantly higher incidence of urgency, urgency
incontinence, difficult urination, and bladder pain occurred
in the DV group compared with the control group (Table 3).
Recurrent UTI was noted in 20 (12%) patients with DV.
The most common co-morbidities were chronic constipation
(27, 16.1%), lower back pain (13, 7.7%), and chronic
obstructive pulmonary disease (COPD; 12, 7.1%). All
patients with symptoms of storage LUTS as the chief
complaint received antimuscarinic therapy and all patients
with symptoms of voiding LUTS as the main complaint
received alpha-blocker treatment with or without a skel-
etal muscle relaxant. The success rates were 41.2%
(nZ 47) for antimuscarinic therapy and 51.9% (nZ 28) for
alpha-blocker therapy in patients with storage and voiding
LUTS, respectively (p Z 0.366).
Discussion
The results of this study revealed that DV is highly prevalent
in women with LUTS. The incidence of DO (69%) and(n Z 168) (n Z 272)
Storage LUTS 167 (99.4%) 270 (99.3%) 0.16
Frequency 158 (94.0%) 260 (95.6%) 0.50
Urgency 147 (87.5%) 163 (60.0%) <0.001
Urgency incontinence 58 (34.5%) 34 (12.5%) <0.001
Nocturia 11 (6.5%) 116 (42.6%) <0.001
Voiding LUTS 88 (52.4%) 100 (36.8%) 0.002
Difficult urination 85 (50.6%) 83 (30.5%) <0.001
Urine retention 7 (0.42%) 8 (2.9%) 0.59
Residual sensation 4 (0.24%) 16 (5.9%) 0.24
Postmicturition LUTS
Terminal dribbling 0 2 (0.74%) 0.53
Pain LUTS 27 (16.1%) 72 (26.5%) 0.013
Bladder pain 23 (13.7%) 64 (24.6%) 0.02
Micturition pain 3 (0.18%) 8 (2.9%) 0.54
DV Z dysfunctional voiding; LUTS Z lower urinary tract
symptoms.
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group compared with the control group. In conjunction with
smaller CBC and the presentation of storage symptoms in
all women, we postulated that part of patients with DV
might be a voiding dysfunction originating from sensory
urgency or DO.
DVwas previously considered as a voiding dysfunction due
to abnormal coordination of the urethral sphincter during
micturition. A high incidence of urodynamic DO is reported in
patients with DV9 and in this study. DO could occur primarily
or secondarily to bladder outlet obstruction (BOO). Previous
studies reported that 48%e53% of men with LUTS had uro-
dynamically proven BOO, and among them, DO was noted in
55%.9,12,13 Bael et al14 suggested that BOO in women and
children was not common but the prevalence of DO in these
two patient groups was high. Treatment of OAB symptoms or
DO by an antimuscarinic agent alone or in combination with
behavior modification have been reported successful.15,16
Our study showed a significantly higher incidence of DO,
smaller CBC, lower Qmax, larger postvoid residual volume,
and higher Pdet in patients with DV compared to those of
the control group. These urodynamic parameters indicate
that the vesicourethral abnormalities of DV are not only due
to BOO, but also exhibit sensory disorders. In patients with
DV, urinary frequency was the most bothersome symptom
and nearly all patients had storage symptoms (urgency,
nocturia, urgency incontinence). Although difficult urina-
tion was also a chief complaint in 32.1% of patients with DV,
all these patients had storage LUTS as their associated
symptoms. These findings suggest that sensory dysfunction,
either primary or secondary to urethral sphincter dysfunc-
tion, plays an important role in the pathophysiology of LUTS
and the development of DV.
The relationship of bladder overactivity and DV are not
clearly elucidated. Investigations based on male adults with
benign prostatic obstruction revealed that DO was induced
after BOO via multiple different pathways.17e19 We found
that urodynamic DO was present in 69% of patients with DV.
High Pdet and narrow urethral sphincter appearance during
VUD are not sufficient to suggest that DO is secondary to
BOO in women with DV. Interestingly, all DV patients had
storage symptoms and about half of the patients with
primary storage symptoms were successfully treated with
antimuscarinics. These results suggest that DO could be
a one of etiology of DV in adult women. A longer treatment
course might improve the success rate.
Normal voiding in neurologically intact humans is
a complex process. Micturition is triggered by the release of
tonic inhibition from the suprapontine centers and release
of the trigger signal from the pontine micturition center.
Relaxation of the urethral sphincter and pelvic floor muscle
via the pudendal and hypogastric nerve innervations are
important in the micturition cycle. Adequate relaxation of
these muscles results in sustained bladder detrusor muscle
contraction. If the coordination between the pelvic floor-
external sphincter complex and the detrusor muscle is
disturbed, DV may ensue.
DV is suggested to result from a learned behavioral
disturbance in early childhood and may be treated by re-
educational therapy.20 Under this consideration, DO might
also be a trigger factor for DV if patients used to hold back
urine at each urgency episode. Long-term increase of theurethral sphincter activity caused by a reflex inhibitory
response to the occurrence of DO could result in spasticity
of the urethral sphincter and finally, functional BOO
appearance during voiding. One previous study showed that
both the pubococcygeal muscle and external urethral
sphincter contributed to DV.21
Diagnosis of DV should take the following clinical char-
acteristics into consideration: (a) clinical history and diffi-
culty in voiding; (b) intermittent free urine flow pattern;
and (c) the exclusion of neurologic disorders or anatomical
abnormality of the bladder outlet.4 Although cystoscopy,
bladder wall thickness, and pressure flow studies could help
with the diagnosis of DV, the definitive diagnose should only
be made by the demonstration of typical external sphincter
contraction during micturition during a sphincter EMG
study22,23 or fluoroscopic visualization of the “spinning top”
urethra sign during voiding.24
VUD study provides advantages for visualization of
bladder outlet narrowing during voiding with high Pdet.
During voiding cystourethrography, the VUD characteristics
of DV are a wide open bladder neck and a dilated proximal
urethra to the level of the external sphincter, which can be
clearly differentiated from the primary bladder neck
dysfunction or urethral stricture in female BOO.24,25
Although VUD studies are effective tools for evaluations
of patients with LUTS, Soygur26 suggested that a detailed
voiding history and physical examination were sufficient for
a correct diagnosis of DV in children.
Previous studies reported 2%e25.5% prevalence of DV in
women with LUTS.27,28 The prevalence of DV (10.5%) in this
study was similar to those in previous reports. Interestingly,
we also found several comorbidities in patients with DV,
including chronic constipation, lower back pain, and COPD.
Chronic constipation occurs frequently in children with
voiding dysfunction.29 Chronic spasticity of pelvic floor
muscles may result in DV and constipation in adult women
as well. UTI could also be a complication if DV is left
untreated.
In our analysis, more patients with DV presented with
difficult urination (32.1%, p < 0.05) and urgency inconti-
nence (15.5%, p < 0.05) as their main symptoms than the
control group (19.9% and 4.8%, respectively). If we
compared all clusters of symptom types, significantly
increased incidence of urgency (87.5%), urgency inconti-
nence (34.5%), and difficult urination (50.6%) occurred in
patients with DV than controls. Interestingly, patients with
DV were less likely to have nocturia than controls. Addi-
tionally, when patients presented with difficult urination as
the chief complaint, the incidence that urgency was also an
associated symptom was significantly higher in DV than
control (77.8% vs. 37.0%, p < 0.05). Difficult urination
combined with urgency seemed to be predictive symptoms
of DV before any urodynamic survey was performed. This
result needs further investigation to clarify the patho-
physiologic link between difficult urination and urgency in
patients with DV.
The first-line treatment of DV based on patients’ main
presenting symptoms was attempted in this study. Although
41.2% of patients were satisfied to antimuscarinic therapy,
51.9% of the patients were satisfied with alpha-blocker
therapy in patients with storage and voiding LUTS,
respectively. Because most of the patients with DV had
Dysfunctional voiding in adult women 165both storage and voiding symptoms and the UDS showed
high voiding pressure in these patients, combined alpha-
blocker and antimuscarinics might provide a better result in
treatment of LUTS in DV. In patients who failed medical
treatment, urethral sphincter botulinum toxin A injection
provides an alternative treatment option. Patients with
voiding dysfunction due to pseudodyssynergia or non-
relaxing urethral sphincter can be treated with 50e100 U
urethral onabotulinumtoxinA (BoNT-A) injection.30 Urethral
BoNT-A injections can be performed in the operation room
under light intravenous general anesthesia (in men) or at
out-patient clinic without anesthesia (in women). A dose of
100 U BoNT-A is adequate for patients with dysfunctional
voiding or poor relaxation of the urethral sphincter.30
Limitation of this study is lack of associated question-
naire used for grading the severity of LUTS in this retro-
spective study.
Conclusion
LUTS storage symptoms, urodynamic DO, and VUD study
features of BOO were present in most women with DV.
Treatment with antimuscarinics or alpha-blockers resulted
in symptomatic relief. A definitive diagnosis of DV could not
be made based on LUTS alone; VUD studies are better
diagnostic tools for accurate diagnosis of DV in women.
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